Valuation: CROSSJECT

Market Cap 7.24Cr 8.23Cr 6.83Cr 6.23Cr 12Cr 790.23Cr 12Cr 82Cr 32Cr 402.18Cr 31Cr 30Cr 1.31TCr P/E 2026 *
3.24x
P/E 2027 * 2.56x
Enterprise Value 5.45Cr 6.2Cr 5.14Cr 4.69Cr 8.77Cr 594.88Cr 8.84Cr 62Cr 24Cr 302.76Cr 23Cr 23Cr 985.22Cr EV / Sales 2026 *
0.9x
EV / Sales 2027 * 0.39x
Free-Float
92.46%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.67%+102.38%+432.44%+1,126.80% 11Cr
+4.61%+5.24%-18.60%-42.24% 9.75Cr
-0.15%+0.15%-20.48%-64.87% 8.23Cr
-0.30%-0.59%+43.59%+28.24% 7.58Cr
Average +26.21%-0.85%+109.24%+261.98% 9.24Cr
Weighted average by Cap. +32.14%-0.51%+132.70%+327.36%

Financials

2026 *2027 *
Net sales 6.08Cr 6.91Cr 5.73Cr 5.23Cr 9.78Cr 663.52Cr 9.86Cr 69Cr 27Cr 337.7Cr 26Cr 25Cr 1.1TCr 6.52Cr 7.41Cr 6.15Cr 5.61Cr 10Cr 711.54Cr 11Cr 74Cr 29Cr 362.13Cr 28Cr 27Cr 1.18TCr
Net income 2.83Cr 3.22Cr 2.67Cr 2.43Cr 4.55Cr 308.84Cr 4.59Cr 32Cr 12Cr 157.18Cr 12Cr 12Cr 511.49Cr 3.56Cr 4.05Cr 3.36Cr 3.06Cr 5.73Cr 388.51Cr 5.77Cr 40Cr 16Cr 197.73Cr 15Cr 15Cr 643.43Cr
Net Debt -1.79Cr -2.04Cr -1.69Cr -1.54Cr -2.88Cr -195.35Cr -2.9Cr -20Cr -7.85Cr -99Cr -7.64Cr -7.47Cr -323.52Cr -4.7Cr -5.34Cr -4.43Cr -4.04Cr -7.56Cr -512.92Cr -7.62Cr -53Cr -21Cr -261.05Cr -20Cr -20Cr -849.48Cr
Logo CROSSJECT
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-